Literature DB >> 22928575

Autocrine regulation of insulin secretion.

M Braun1, R Ramracheya, P Rorsman.   

Abstract

Impaired insulin secretion from pancreatic β-cells is a major factor in the pathogenesis of type 2 diabetes. The main regulator of insulin secretion is the plasma glucose concentration. Insulin secretion is modified by other nutrients, circulating hormones and the autonomic nervous system, as well as local paracrine and autocrine signals. Autocrine signalling involves diffusible molecules that bind to receptors on the same cell from which they have been released. The first transmitter to be implicated in the autocrine regulation of β-cell function was insulin itself. The importance of autocrine insulin signalling is underscored by the finding that mice lacking insulin receptors in β-cells are glucose intolerant. In addition to insulin, β-cells secrete a variety of additional substances, including peptides (e.g. amylin, chromogranin A and B and their cleavage products), neurotransmitters (ATP and γ-aminobutyric acid) and ions (e.g. zinc). Here we review the autocrine effects of substances secreted from β-cells, with a focus on acute effects in stimulus-secretion coupling, present some novel data and discuss the general significance of autocrine signals for the regulation of insulin secretion.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22928575     DOI: 10.1111/j.1463-1326.2012.01642.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  32 in total

Review 1.  Contribution of calcium-conducting channels to the transport of zinc ions.

Authors:  Alexandre Bouron; Johannes Oberwinkler
Journal:  Pflugers Arch       Date:  2013-05-30       Impact factor: 3.657

Review 2.  Regulatory role of adenosine in insulin secretion from pancreatic β-cells--action via adenosine A₁ receptor and beyond.

Authors:  Tomasz Szkudelski; Katarzyna Szkudelska
Journal:  J Physiol Biochem       Date:  2014-11-30       Impact factor: 4.158

3.  Islet amyloid-induced cell death and bilayer integrity loss share a molecular origin targetable with oligopyridylamide-based α-helical mimetics.

Authors:  Sunil Kumar; Diana E Schlamadinger; Mark A Brown; Joanna M Dunn; Brandon Mercado; James A Hebda; Ishu Saraogi; Elizabeth Rhoades; Andrew D Hamilton; Andrew D Miranker
Journal:  Chem Biol       Date:  2015-03-05

4.  Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion.

Authors:  Despoina Aslanoglou; Emily W George; Zachary Freyberg
Journal:  J Vis Exp       Date:  2018-05-10       Impact factor: 1.355

5.  Six cases of (severe) hypoglycaemia associated with gabapentin use in both diabetic and non-diabetic patients.

Authors:  Joep H G Scholl; Rike van Eekeren; Eugène P van Puijenbroek
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

6.  β-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice.

Authors:  Magalie A Ravier; Michele Leduc; Joy Richard; Nathalie Linck; Annie Varrault; Nelly Pirot; Morgane M Roussel; Joël Bockaert; Stéphane Dalle; Gyslaine Bertrand
Journal:  Diabetologia       Date:  2013-12-07       Impact factor: 10.122

7.  P2X receptor channels in endocrine glands.

Authors:  Stanko S Stojilkovic; Hana Zemkova
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2013

8.  Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.

Authors:  Dale S Edgerton; Guillaume Kraft; Marta Smith; Ben Farmer; Phillip E Williams; Katie C Coate; Richard L Printz; Richard M O'Brien; Alan D Cherrington
Journal:  JCI Insight       Date:  2017-03-23

Review 9.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

10.  Autocrine activation of P2Y1 receptors couples Ca (2+) influx to Ca (2+) release in human pancreatic beta cells.

Authors:  Shara Khan; Richard Yan-Do; Eric Duong; Xichen Wu; Austin Bautista; Stephen Cheley; Patrick E MacDonald; Matthias Braun
Journal:  Diabetologia       Date:  2014-09-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.